Table S1. Descriptive characteristics of breast cancer cases and non-cancer controls. (DOCX 17 kb
Table S5. Results of OncoScore analyses for the 164 differentially-methylated and differentially-exp...
Methods description, figures, and tables can be found at the Clinical Epigenetics webpage. (DOCX 282...
Table S3. List of CpGs located in genes that are differentially expressed between breast cancer and ...
Table S2. Summary statistics of the 568 CpGs which remain significantly altered by chemotherapy afte...
Table S3. Pathway enrichment analysis of significant CpG sites altered between pre- and post-chemoth...
Figure S1. Changes in leukocyte composition before and after chemotherapy by treatment regimen, grow...
Description of the four prospective studies. Also, a figure with the results of the association betw...
Table S1. Clinical table of normal individuals and cancer patients. Table S2. Primer sequences. Tabl...
Table S1. List of CpGs differently methylated between breast cancer and matched-normal samples. (XLS...
Table S4. List of genes differently expressed between normal and tumor METABRIC samples and with con...
Figure S1. Box plot showing the methylation levels of 14 genes in the control and luminal breast can...
Comparison of DNA methylation frequency of genes screened in breast carcinomas with the methylation ...
Mean differences in methylation levels according to clinicopathological prognostic factors in both c...
DNA methylation levels in various types of samples from BC patients with different histological grad...
Eleven differentially methylated CpGs, corresponding to 11 genes, showed significant methylation dif...
Table S5. Results of OncoScore analyses for the 164 differentially-methylated and differentially-exp...
Methods description, figures, and tables can be found at the Clinical Epigenetics webpage. (DOCX 282...
Table S3. List of CpGs located in genes that are differentially expressed between breast cancer and ...
Table S2. Summary statistics of the 568 CpGs which remain significantly altered by chemotherapy afte...
Table S3. Pathway enrichment analysis of significant CpG sites altered between pre- and post-chemoth...
Figure S1. Changes in leukocyte composition before and after chemotherapy by treatment regimen, grow...
Description of the four prospective studies. Also, a figure with the results of the association betw...
Table S1. Clinical table of normal individuals and cancer patients. Table S2. Primer sequences. Tabl...
Table S1. List of CpGs differently methylated between breast cancer and matched-normal samples. (XLS...
Table S4. List of genes differently expressed between normal and tumor METABRIC samples and with con...
Figure S1. Box plot showing the methylation levels of 14 genes in the control and luminal breast can...
Comparison of DNA methylation frequency of genes screened in breast carcinomas with the methylation ...
Mean differences in methylation levels according to clinicopathological prognostic factors in both c...
DNA methylation levels in various types of samples from BC patients with different histological grad...
Eleven differentially methylated CpGs, corresponding to 11 genes, showed significant methylation dif...
Table S5. Results of OncoScore analyses for the 164 differentially-methylated and differentially-exp...
Methods description, figures, and tables can be found at the Clinical Epigenetics webpage. (DOCX 282...
Table S3. List of CpGs located in genes that are differentially expressed between breast cancer and ...